I
t is well established that the central nervous system contains an intrinsic angiotensin (Ang) generating system that may be involved in the regulation of blood pressure and fluid balance. However, because specific high-affinity Ang II binding sites have been reported on both neurons and glia, 1 " 6 it is unclear whether many of the central actions of Ang II are mediated by direct effects on neuronal or glial elements or both. Glial cells contain many components of an Ang generating system, 78 including the presence of angiotensinogen mRNA in several human astrocyte cell lines in culture. intracellular calcium. 10 We also showed that Ang II enhances the release of prostaglandin (PG) E2 and prostacyclin (PGI 2 ) from rat C6 glioma cells 11 and human astrocytes, 10 in agreement with earlier studies. 12 - 13 Furthermore, using the two Ang heptapeptides Ang- (2) (3) (4) (5) (6) (7) (8) and Ang-(l-7), we showed that the increase in PG release can be dissociated from the increase in intracellular calcium by the differential actions of these two peptides. 10 The two responses (PG release and Ca 2+ mobilization) may be due to the presence of multiple Ang receptor subtypes coupled to different signal transduction pathways or to a single receptor coupled to multiple signal transduction pathways generating different responses.
Recent studies using selective Ang II receptor antagonists have provided evidence for at least two Ang II receptor subtypes. Subtype 2 (AT 2 ) receptors are present in mammalian uterus, the adrenal gland, and in differentiated NG108-15 cells as demonstrated by the high affinity (nanomolar) of CGP 42112A for these sites. 
Culturing of Human Astrocytes
Human astrocyte cells were cultured from neoplastic brain tissues of patients undergoing excision of tumor masses and were demonstrated to be positive for glial acidic fibrillary protein. 918 Cells were cultured in RPMI 1640, 10% fetal bovine serum, 4 mM L-glutamine, 100 units/ml penicillin G sodium, and 100 ixg/m\ streptomycin sulfate at 37°C in a humidified atmosphere of 95% Oj-5% CO 2 . All cells were used between passages five and 11.
Experimental Protocol for Prostaglandin Studies
For PG studies, confluent monolayers grown in 24-well plates were washed twice with Hanks' balanced salt solution containing 5.5 mM glucose and 1.8 mM CaCl 2 and then were incubated with various agonists for 15 minutes at 37°C in 5% COj-95% air as previously described. 19 At the end of the incubation period, media were removed and kept at -20°C for measurement of PGE2 and 6-keto-PGF la by radioimmunoassay. 19 To 2 1, and HEPES 25) containing 0.1% bovine serum albumin to completely hydrolyze the entrapped ester. The fura-2 signal was calibrated using excitation wavelengths of 340 and 380 nM and an emission wavelength of 510 nM in an air-driven turbine dual-wavelength spectrofluorometer. Maximal fluorescence of the Ca 2+ -saturated dye was measured after the cells were lysed by the addition of digitonin, and minimal fluorescence was measured by the addition of Tris buffer (pH 8.5) to 32 mM and EGTA to 5 mM. The level of cytosolic Ca 2+ was calculated according to the procedure of Grynkiewicz et al. 20 Results Figure 1 illustrates the effect of [Sar As shown in Figure 2A , DuP 753 (10~6 M) (n=9) completely blocked the PGE2 response elicited by Ang II but did not alter release in response to Ang-(l-7) ( Figure 2B ). In contrast, 6-keto-PGF la release produced by Ang II or Ang-(l-7) was not inhibited by DuP 753 at 10" 6 M. In fact, DuP 753 alone was a potent stimulus for 6-keto-PGF la release, as reported previously. 19 DuP 753 alone at 10" 6 M stimulated PGEj and 6-keto-PGF la release 115±33% and 641 ±14% above basal, respectively (n=5).
Effect of Angiotensin Receptor Antagonists on Prostaglandin Release
CGP 42112A, an ATz-selective antagonist, partially attenuated the Ang II-induced release of PGE2 at the highest dose tested ( Figure 3A) . The response to Ang-(l-7) was more sensitive to antagonism by this blocker, because a reduction in PGEj release was achieved at both 10~7 and 10" 6 M CGP 42112A ( Figure 3B ). The 6-keto-PGF la release produced by either Ang II or Ang-(l-7) was completely abolished by CGP 42112A. Basal PGEj and 6-keto-PGF, a production was not significantly altered by 10~8 and 10~7 M CGP 42112A. CGP 42112A alone at 10" 6 M enhanced PGE2 and 6-keto-PGF la release by 93±17% and 123±51% above basal, respectively (n=7). Ang II (100 nM) produced an increase in intracellular Ca 2+ concentration ( Figure 4A ), whereas Ang-(1-7) was without effect, as reported previously. The actual values ranged from no reduction to a 46% reduction in peak height. Even at 10" 5 M CGP tively stimulated by Ang-(l-7). Previous studies indicated that rat astrocytes contain Ang II binding sites 1 and that astrocytes are the primary source of PGs in the brain. 21 We now show that astrocytes possess two distinct Ang receptor subtypes that are coupled to different signal transduction pathways (arachidonic acid release and phosphoinositide-specific phospholipase C activation). That Ang II and Ang-(l-7) act Ang II is known to stimulate PG synthesis in both central and peripheral tissues by the activation of specific phospholipases. , which could activate a Ca 2+ -dependent phospholipase A 2 and release arachidonic acid for PG synthesis, whereas diacylglycerol also could serve as a source of arachidonic acid and result in the production of PG. Alternatively, the activation of phosphatidylcholine-specific phospholipase C or phospholipase D also can release ara-chidonic acid in a Ca 2+ -independent manner. In the present study, Ang-(l-7) stimulated PG release without increasing intracellular Ca 2+ , suggesting that Ang-(l-7) stimulates PG release through a Ca 2+ -independent phospholipase. Recent studies have demonstrated that bradykinin stimulated PGE2 production in Madin-Darby canine kidney cells by a mechanism independent of activation of phospholipase C. 27 The Ang II-induced increase in intracellular Ca 2+ was blocked by DuP 753 but not by CGP 42112A, suggesting that the AT, receptor is coupled to Ca 2+ mobilization. In contrast, Ang II-stimulated PG synthesis was mediated through activation of both AT, and AT 2 receptors. These results suggest that both a phosphoinositide-specific phospholipase C as well as an additional phospholipase are coupled to different subtypes of Ang receptors. Ang-(l-7) stimulated PG synthesis through the activation of AT 2 receptors without increasing the intracellular Ca 2+ concentration. These data indicate that release of arachidonic acid in human astrocytes in response to Ang-(l-7) may be independent of activation of a phosphoinositide-specific phospholipase C. Indeed, Ca
2+
-independent phospholipase D or phosphatidylcholine-specific phospholipase C may generate diacylglycerol to serve as a substrate for arachidonic acid. n Furthermore, [Sar^Ile'JAng II antagonizes the pressor effect of Ang II but not of Ang-(2-8) in conscious rats, suggesting that this antagonist is capable of discrimination between different receptor subtypes. 29 ' 30 Thus, the data are consistent with the concept that the endogenous heptapeptides show selectivity for the Ang receptor subtypes.
Recent biochemical and pharmacological studies using selective antagonists provide compelling new evidence for the presence of distinct Ang II receptor subtypes in different tissues. 1413 Moreover, two distinct Ang II receptor subtypes have been reported in rat brain based on their sensitivity toward two sulfhydryl reducing agents and DuP 753. 31 Our findings would indicate that regulation of cellular events by Ang peptides may depend not only on the presence of different receptor subtypes but also on the Ang peptide present in different tissues. For example, Ang II and Ang-(2-8) exhibit different abilities to stimulate aldosterone release or to cause vasoconstriction.
2932 - 34 Furthermore, we have shown that Ang-(l-7) is as potent as Ang II in releasing vasopressin, in producing neuronal excitation and cardiovascular effects in the dorsal medulla, and in stimulating PG release from vas deferens, C6 glioma cells, and human astrocytes.
1011 ' 35 ' 3 * However, Ang-(l-7) is devoid of dipsogenic, pressor, or direct myotropic effects. 35 The occurrence and formation of PGs in the brain of several species is well established, and astrocytes are considered a major source of PGs and thromboxanes. 37 ' 38 In contrast, cultured neurons display low but measurable cyclooxygenase activity. 38 ' 39 PGs in the central nervous system have been implicated in regulation of cerebral blood flow and blood-brain barrier permeability, 39 -40 actions also attributed to Ang II. 40 With the recent report that Ang II-stimulated vasopressin release is mediated through PG, 41 the possibility that many of the known central nervous system actions of Ang II involve an interaction with PGs must be considered.
In conclusion, the results presented provided the first evidence for a functional AT 2 receptor. In cultured astrocytes, two Ang receptor-mediated signal transduction pathways (Ca 2+ mobilization and PG release) were activated via different subtypes of Ang receptors. Ang II-stimulated PG synthesis was mediated via activation of both AT, and AT 2 Ang II receptors, whereas the Ang II-induced Ca 2+ mobilization was exclusively mediated via AT, receptors. In contrast, Ang-(l-7) stimulated PG release via activation of AT 2 Ang receptors without any enhancement in intracellular Ca 2+ . Because the astroglial cells are the primary source of PGs in the central nervous system and Ang-(l-7) is endogenously present in brain, the potent stimulatory effects of Ang-(l-7) on PG release in astrocytes have important physiological implications.
